Kseniya A. Polukhina
About Kseniya A. Polukhina
Kseniya A. Polukhina is an Associate Scientist at Bristol Myers Squibb in Seattle, Washington, specializing in Cell Therapy Analytical Development with a focus on Molecular Assays.
Current Role at Bristol Myers Squibb
Kseniya A. Polukhina currently serves as an Associate Scientist at Bristol Myers Squibb in Seattle, Washington. She began her tenure in this role in December 2021. Her work mainly involves cell therapy analytical development, focusing on molecular assays. Given her background in both clinical and research settings, she brings a wealth of experience to her current role and contributes significantly to the company’s research and development efforts.
Previous Roles and Experience
Kseniya has built an extensive career in the biotechnology and pharmaceuticals sectors. She worked at Sana Biotechnology, Inc. as a Principal Research Associate for seven months in 2021. Before that, she was a Senior Research Associate at Juno Therapeutics, Inc. from 2018 to 2021. Her earlier roles include a Research Technician II in gene and stem cell therapies at Fred Hutch and various internship and consultancy positions. She has accumulated expertise in molecular assays, cell therapy, and clinical operations.
Educational Background
Kseniya holds a Master of Bioscience in Pharmaceutical Discovery and Development from Keck Graduate Institute, earned between 2015 and 2017. She also obtained a Bachelor of Arts in Ethics, Society, and Human Behavior and Human Rights from the University of Washington Bothell, completed between 2012 and 2015. Her academic background has provided a solid foundation for her multifaceted career in biotechnology and pharmaceutical industries.
Special Projects and Research Contributions
Throughout her career, Kseniya has contributed to several significant projects. She worked on optimizing an in vitro diagnostic device for low-resource settings and participated in a market analysis for treating ricin poisoning. Additionally, she contributed to the development of a biosimilar pathway for a biologic facing an upcoming patent expiration. These projects demonstrate her versatility and commitment to advancing medical and scientific research.
Experience in Clinical and Research Settings
Kseniya's experience spans both clinical and research environments. At Fred Hutch, she worked in the Clinical Research Division on gene and stem cell therapies. She further honed her research skills during her time at Keck Graduate Institute, where she was involved in various projects, including drug discovery and market analysis. Her diverse background equips her with a unique perspective and skillset in the biotechnology and pharmaceutical fields.